Medicaid Drug Rebates. Reforms to Medicare Part D. CMS guidance on coverage gap in Medicare Part D. Medicaid Drug Rebates. Reforms to Medicare Part D. S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program.  
H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: AMP provision; 340b provisions. H.R.4899, Supplemental Appropriations Act of 2010: Patent Settlement provisions; 340b provisions. S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. Support for H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program. 
S.369, Preserve Access to Affordable Generics Act. Support for H.R. 1548, Pathway for Biologics Act. H.R. 2502, Comparative Effectiveness Research Act of 2009. Changes to the 340b program.
MMM - Medicare/Medicaid HCR - Health Issues PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
JONATHON JONES SEAN RICHARDSON SHEILA MURPHY JOHN MICHAEL GONZALEZ JONATHON JONES SEAN RICHARDSON SHEILA MURPHY JOHN MICHAEL GONZALEZ JONATHON JONES SEAN RICHARDSON SHEILA MURPHY JOHN MICHAEL GONZALEZ JONATHON JONES SEAN RICHARDSON SHEILA MURPHY JOHN MICHAEL GONZALEZ